Literature DB >> 29785531

Prevalent genotypes of methylenetetrahydrofolate reductase (MTHFR) in recurrent miscarriage and recurrent implantation failure.

Yuanchang Zhu1,2, Tonghua Wu3, Lijun Ye3, Guangui Li3, Yong Zeng3, Yaou Zhang4.   

Abstract

OBJECTIVE: To evaluate the association of two common methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms with recurrent miscarriage (RM) and repeated implantation failure (RIF)
METHODS: The study comprised of 521 patients, with a history of RM (n = 370) or RIF (n = 151). One hundred forty-four women with fallopian tube blockages who had successfully conceived after the first in vitro fertilization embryo transfer treatment served as the control group. The MTHFR alleles, genotypes, and haplotypes were assessed in different groups.
RESULTS: There was no difference in allele frequency and distribution of MTHFR polymorphisms between case and control patients. The 1298AA genotype was represented in a higher frequency, and 1298AC genotype was significantly lower in subfertile group when compared to the control group. A significant relationship was found between the 1298AC genotype and the RIF subgroup. The haplotype 677CC/1298AA was overrepresented in the RM subgroup (> 2 times) and haplotype 677CC/1298AC was underrepresented in the RIF subgroup (P < 0.05). Nevertheless, these two haplotypes were not connected to fertilization and embryo cleavage rates.
CONCLUSION: Our findings indicate that the MTHFR gene polymorphism might play a role in the etiology of patients with RM or RIF. No adverse effects of different MTHFR haplotypes on embryo development were detected. Further studies on the biological role are needed to better understand the susceptibility to pregnancy complications.

Entities:  

Keywords:  Genotype; MTHFR; Polymorphism; Recurrent miscarriage; Repeated implantation failure

Mesh:

Substances:

Year:  2018        PMID: 29785531      PMCID: PMC6086799          DOI: 10.1007/s10815-018-1205-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

Review 1.  Recent thoughts on management and prevention of recurrent early pregnancy loss.

Authors:  Ai-Wei Tang; Siobhan Quenby
Journal:  Curr Opin Obstet Gynecol       Date:  2010-12       Impact factor: 1.927

2.  Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis.

Authors:  Tarek A Abd El-Aziz; Rasha H Mohamed
Journal:  Gene       Date:  2017-02-12       Impact factor: 3.688

3.  Recurrent implantation success in consecutive embryo transfer cycles: a unique case report.

Authors:  Sanghamitra Ghosh; Ratna Chattopadhyay; Sourendrakant Goswami; Ashalatha Ganesh; Koel Chaudhury; Baidyanath Chakravarty
Journal:  Syst Biol Reprod Med       Date:  2013-05-08       Impact factor: 3.061

4.  Laparoscopic endometrioma resection increases peri-implantation endometrial HOXA-10 and HOXA-11 mRNA expression.

Authors:  Onder Celik; Cihat Unlu; Baris Otlu; Nilufer Celik; Eray Caliskan
Journal:  Fertil Steril       Date:  2015-06-13       Impact factor: 7.329

5.  Folic acid in early pregnancy: a public health success story.

Authors:  Sarah G Obican; Richard H Finnell; James L Mills; Gary M Shaw; Anthony R Scialli
Journal:  FASEB J       Date:  2010-07-14       Impact factor: 5.191

6.  Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.

Authors:  Yunlei Cao; Jianhua Xu; Zhaofeng Zhang; Xianliang Huang; Aiping Zhang; Jian Wang; Qiupeng Zheng; Lingyuan Fu; Jing Du
Journal:  Gene       Date:  2012-11-29       Impact factor: 3.688

7.  Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women.

Authors:  P R Barbosa; S P Stabler; A L K Machado; R C Braga; R D C Hirata; M H Hirata; L F Sampaio-Neto; R H Allen; E M Guerra-Shinohara
Journal:  Eur J Clin Nutr       Date:  2007-05-23       Impact factor: 4.016

8.  Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation.

Authors:  Yi Yang; Yunyao Luo; Jing Yuan; Yidan Tang; Lang Xiong; MangMang Xu; XuDong Rao; Hao Liu
Journal:  Arch Gynecol Obstet       Date:  2015-11-03       Impact factor: 2.344

Review 9.  Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome.

Authors:  Silvia Vannuccini; Vicki L Clifton; Ian S Fraser; Hugh S Taylor; Hilary Critchley; Linda C Giudice; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2015-09-22       Impact factor: 15.610

10.  Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of Han nationality.

Authors:  Boyi Yang; Yuyan Liu; Yongfang Li; Shujun Fan; Xueyuan Zhi; Xiangxiang Lu; Da Wang; Quanmei Zheng; Yinuo Wang; Yanxun Wang; Guifan Sun
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more
  3 in total

1.  LncRNA HULC Polymorphism Is Associated With Recurrent Spontaneous Abortion Susceptibility in the Southern Chinese Population.

Authors:  Zhenzhen Fang; Yanfang Yang; Yufen Xu; Hanran Mai; Wanqi Zheng; Lei Pi; Lanyan Fu; Huazhong Zhou; Yaqian Tan; Di Che; Xiaoqiong Gu
Journal:  Front Genet       Date:  2019-10-04       Impact factor: 4.599

2.  The association between 5, 10 - methylenetetrahydrofolate reductase and the risk of unexplained recurrent pregnancy loss in China: A Meta-analysis.

Authors:  Genzhu Wang; Zhaohui Lin; Xiaoying Wang; Qiang Sun; Zhikun Xun; Baiqian Xing; Zhongdong Li
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

3.  MTHFR 677TT is associated with decreased number of embryos and cumulative live birth rate in patients undergoing GnRHa short protocol: a retrospective study.

Authors:  Hong Zeng; Zefu Liu; Lei Zhang; Nenghui Liu
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-01       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.